Cargando…
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
Melanoma is characterised by its ability to metastasise at early stages of tumour development. Current clinico‐pathologic staging based on the American Joint Committee on Cancer criteria is used to guide surveillance and management in early‐stage disease, but its ability to predict clinical outcome...
Autores principales: | Rabbie, Roy, Ferguson, Peter, Molina‐Aguilar, Christian, Adams, David J, Robles‐Espinoza, Carla D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492003/ https://www.ncbi.nlm.nih.gov/pubmed/30511391 http://dx.doi.org/10.1002/path.5213 |
Ejemplares similares
-
Desmoplastic melanoma: C>Ts and NF‐κB
por: Rabbie, Roy, et al.
Publicado: (2016) -
Spontaneously occurring melanoma in animals and their relevance to human melanoma
por: van der Weyden, Louise, et al.
Publicado: (2020) -
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
por: Menezes, Shinelle, et al.
Publicado: (2022) -
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017) -
Genomic analysis and clinical management of adolescent cutaneous melanoma
por: Rabbie, Roy, et al.
Publicado: (2017)